BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
M. Sidorkiewicz, M. Grek, B. Jozwiak, A. Krol, A. Piekarska. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expressionEuropean Journal of Clinical Microbiology & Infectious Diseases 2017; 36(4): 697 doi: 10.1007/s10096-016-2851-1
2
Emilie Crouchet, Thomas F. Baumert, Catherine Schuster. Hepatitis C virus–apolipoprotein interactions: molecular mechanisms and clinical impactExpert Review of Proteomics 2017; 14(7): 593 doi: 10.1080/14789450.2017.1344102
3
Joana Rita Carvalho, José Velosa, Fátima Serejo. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimensScandinavian Journal of Gastroenterology 2018; 53(7): 857 doi: 10.1080/00365521.2018.1473486
4
Takeshi Chida, Kazuhito Kawata, Kazuyoshi Ohta, Erika Matsunaga, Jun Ito, Shin Shimoyama, Satoru Yamazaki, Hidenao Noritake, Tetsuro Suzuki, Takafumi Suda, Yoshimasa Kobayashi. Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1bGut and Liver 2018; 12(2): 201 doi: 10.5009/gnl17179
5
Laura Pellegrini, Anna Albecka, Donna L. Mallery, Max J. Kellner, David Paul, Andrew P. Carter, Leo C. James, Madeline A. Lancaster. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain OrganoidsCell Stem Cell 2020;  doi: 10.1016/j.stem.2020.10.001
6
Daisuke Endo, Kenichi Satoh, Noritomo Shimada, Atsushi Hokari, Yoshio Aizawa. Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1bWorld Journal of Gastroenterology 2017; 23(13): 2355-2364 doi: 10.3748/wjg.v23.i13.2355
7
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
8
Mohammed A. Sarhan, Mohamed S. Abdel-Hakeem, Andrew L. Mason, D. Lorne Tyrrell, Michael Houghton. Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolismScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02648-6
9
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Takeshi Matsui, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virusHepatology Research 2018; 48(3): E203 doi: 10.1111/hepr.12970
10
Eric Piver, Audrey Boyer, Julien Gaillard, Anne Bull, Elodie Beaumont, Philippe Roingeard, Jean-Christophe Meunier. Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocaptureGut 2017; 66(8): 1487 doi: 10.1136/gutjnl-2016-311726
11
Srikanta Dash, Yucel Aydin, Christopher M. Stephens. Viral Polymerases2019; : 211 doi: 10.1016/B978-0-12-815422-9.00008-5
12
ARZU ALTUNÇEKİÇ YILDIRIM, Selma Cırrık, Yeliz Çetinkol, Mustafa Kerem Çalgın, Tevfik Noyan. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control studyJournal of Surgery and Medicine 2019;  doi: 10.28982/josam.595537
13
Srikanta Dash, Srinivas Chava, Yucel Aydin, Partha Chandra, Pauline Ferraris, Weina Chen, Luis Balart, Tong Wu, Robert Garry. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseViruses 2016; 8(5): 150 doi: 10.3390/v8050150
14
Yuyan Gui, Nan Chu, Xuemin Qiu, Wei Tang, Hans-Jürgen Gober, Dajin Li, Ling Wang. 17-β-estradiol up-regulates apolipoprotein genes expression during osteoblast differentiation <i>in vitro </i>BioScience Trends 2016; 10(2): 140 doi: 10.5582/bst.2016.01007
15
Gilmar de Souza Lacerda, Thalia Medeiros, Natalia Fonseca do Rosário, Regina Helena Saramago Peralta, Mauro Jorge Cabral-Castro, Eliane Bordalo Cathalá Esberard, Thaís Guaraná de Andrade, Analúcia Rampazzo Xavier, Andrea Alice Silva. Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatmentClinical Biochemistry 2018; 60: 17 doi: 10.1016/j.clinbiochem.2018.07.007
16
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
17
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
18
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen. Humanized Mouse Models for the Study of Hepatitis C and Host InteractionsCells 2019; 8(6): 604 doi: 10.3390/cells8060604
19
Daisuke Morihara, Yi‐Ling Ko, Kumiko Shibata, Ryo Yamauchi, Hiromi Fukuda, Naoaki Tsuchiya, Atsushi Fukunaga, Hideo Kunimoto, Hideyuki Iwashita, Kazuhide Takata, Takashi Tanaka, Kunitoshi Sakurai, Shinjiro Inomata, Keiji Yokoyama, Shinya Nishizawa, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka. IL28B gene polymorphism is correlated with changes in low‐density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct‐acting antiviral treatment Journal of Gastroenterology and Hepatology 2019; 34(11): 2019 doi: 10.1111/jgh.14741
20
Chengliang Zhu, Guosheng Gao, Hui Song, Fengxia Xu, Kailang Wu, Xinghui Liu. Hepatitis B virus inhibits apolipoprotein A5 expression through its core geneLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0340-2
21
Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Thomas F. Baumert. Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine DesignFrontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01436
22
Jihong Lian, Randal Nelson, Richard Lehner. Carboxylesterases in lipid metabolism: from mouse to humanProtein & Cell 2018; 9(2): 178 doi: 10.1007/s13238-017-0437-z
23
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antiviralsJGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
24
Rie Harada, Masako Kimura, Yasushi Sato, Tatsuya Taniguchi, Tetsu Tomonari, Takahiro Tanaka, Hironori Tanaka, Naoki Muguruma, Hirohiko Shinomiya, Hirohito Honda, Issei Imoto, Masahiro Sogabe, Toshiya Okahisa, Tetsuji Takayama. APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolismBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0747-5